MedPath

Evaluation of treatment of actinic keratosis with KOH5% solution in comparison to Fluorouracil 5% cream

Phase 3
Conditions
Actinic Keratosis.
Actinic keratosis
Registration Number
IRCT20180909040978N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Patients suffering Actinic Keratosis attending Razi dermotology hospital
Having at least 18 years of age
Having a minimum number of 8 lesions( 4 on each side, at least) on parts of skin that are exposed to the sun.

Exclusion Criteria

Pregnant women
People with a history of allergy to any of the drugs under study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Smoothing of Actinic Keratosis's lesions' roughness. Timepoint: At the beginning of the study (Before the intervention begins) and 14, 28, 60 and 90 days after starting the use of KOH 5% solution and Fluorouracil cream. Method of measurement: Clinical diagnosis by dermatologist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath